Reduction of chronic pain for non-postherpetic peripheral neuropathies after topical treatment with a lidocaine patch;Reduktion chronischer schmerzen bei nichtpostherpetischen peripheren neuropathien nach topischer behandlung mit lidocainpflaster

Schmerz

Volumn 18, Issue 3, 2004, Pages 172-178

  Meier, T ^a   Faust, M ^a   Huppe M ^a   Schmucker, P ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Lidocaine; Peripheral neuropathy; Placebo controlled study; Topical therapy

Indexed keywords

LIDOCAINE; PLACEBO;

ALLODYNIA; ANALGESIA; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HUMAN; NOCICEPTION; PAIN ASSESSMENT; PERIPHERAL NEUROPATHY; POSTHERPETIC NEURALGIA; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN IRRITATION; STATISTICAL ANALYSIS; TREATMENT INDICATION;

ADMINISTRATION, TOPICAL; AGED; AGED, 80 AND OVER; ANESTHETICS, LOCAL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LIDOCAINE; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; PLACEBOS; SKIN;

EID: 3042765965     PISSN: 0932433X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Attal N, Brasseur L, Chauvin M, Bouhassira D (1999) Effects of single and repeated applications of a eutectic mixture of local anaesthetics (EMLA) cream on spontaneous and evoked pain in post-herpetic neuralgia. Pain 81:203-209
2. Benedittis GD, Lorenzetti A (1996) Topical asperin/diethyl either mixture versus indomethacin and diclofenac/diethylether mixtures for acute herpetic neuralgia and postherpetic neuralgia: a double-blind crossover placebo-controlled study. Pain 65:45-51
3. + currents in rat sensory neurons. Anesthesiology 94: 137-144
4. Bridges D, Thompson SWN, Rice ASC (2001) Mechanisms of neuropathic pain. Br J Anaesth 87:12-26
5. Bullinger M (1995) German translation and psychometric testing of the SF-36 health survey: preliminary results from the IQOLA project. Soc Sci Med 41: 1359-1366
6. Carter GT, Galer BS (2001) Advances in the management of neuropathic pain. Phys Med Rehabil Clin N Am 12:447-4S9
7. Devers A, Galer BS (2000) Topical lidocaine patch relieves a variety of neuropathic pain conditions: an open label study. Clin J Pain 16:205-208
8. Ellert U, Bellach BM (1999) Der SF-36 im Bundes-Gesundheitssurvey - Beschreibung einer aktuellen Stichprobe. Gesundheitswesen 61:S184-S190
9. Galer BS, Jensen MP (1997) Development and preliminary validation of a pain measure specific to neuropathic pain: the neuropathic pain scale. Neurology 48: 332-338
10. Galer BS, Rowbotham MC, Perander J, Friedmann E (1999) Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain 80: 533-538
11. Galer BS, Jensen MP, Ma T, Davies PS, Rowbotham MC (2002) The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale. Clin J Pain 18: 297-301
12. Gammaitoni AR, Davis MW (2002) Pharmacokinetics and tolerability of lidocaine patch 5% with extended dosing. Ann Pharmacother 36:236-240
13. Gammaitoni AR, Alvarez NA, Galer BS (2003) Safety and tolerability of lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature. J Clin Pharmacol 43:111-117
14. Geissner E (1996) Die Schmerzempfindungsskala (SES). Hogrefe, Göttingen, S 8-30
15. Gerbershagen HU, Lindena G, Korb J, Kramer S (2002) Gesundheitsbezogene Lebensqualität bei Patienten mit chronischen Schmerzen. Schmerz 16:271-284
16. Hautzinger M, Bailer (1992) ADS Allgemeine Depressionsskala, Manual. Beltz, Weinheim, S 7-32
17. Kingery WS (1997) A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain 73:123-139
18. Koltzenburg M, Scadding J (2001) Neuropathic pain. Curr Opin Neurol 14:641-647
19. Likar R, Sittl R (2002) Praxis der transdermalen Schmerztherapie. Uni-Med Sience, Bremen London Boston, S 119-120
20. Meyer-Rosberg K, Kvarnström A, Kinnman E, Gordh T, Nordfors LO, Kristofferson A (2001) Peripheral neuropathic pain - a multidimensional burden for patients. Eur J Pain 5: 379-389
21. Nagel B, Gerbershagen HU, Lindena G, Pfingsten M (2002) Entwicklung und empirische Überprüfung des Deutschen Schmerzfragebogens der DGSS. Schmerz 16: 263-270
22. Rice ASC, Maton S, Postherpetic Neuralgia Study Group (2001) Gabapentin in postherpetic neuralgia: a randomized, double blind, placebo controlled study. Pain 94: 215-224
23. Rowbotham MC, Davies PS, Verkempinck CM, Galer BS (1996) Lidocaine patch: double-blind controlled study of a new treatment method for postherpetic neuralgia. Pain 65:39-44
24. Rowbotham MC, Harden N, Stacey B, Bernstein P, Magnus-Miller L (1998) Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 280:1837-1842
25. Schmitt N, Gerbershagen HU (1990) The Mainz pain staging system (MPSS) for chronic pain. Pain [Suppl] 5: 484
26. Sindrup HS, Jensen TS (1999) Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 83: 389-400
27. Wasner GL, Kleinert A, Schattschneider J, Binder A, Baron R (2002) Topical lidocaine targets myelinated fibers rather than nociceptors in neuropathic pain. 10th World Congress on Pain, IASP Press, San Diego, p 892-P162
28. Watson CP (1994) Topical capsaicin as an adjuvant analgesic. J Pain Symptom Manage 9:42S-433
29. Watson CP, Evans RJ (1992) The post-mastectomy pain syndrome and topical capsaicin: a randomized trial. Pain 51:375-379
30. Zerssen D von (1976) Die Beschwerden-Liste, Manual. Beltz, Weinheim, S 6-13